AU2136788A - Production of ricin toxins in a baculovirus-insect cell expression system - Google Patents

Production of ricin toxins in a baculovirus-insect cell expression system

Info

Publication number
AU2136788A
AU2136788A AU21367/88A AU2136788A AU2136788A AU 2136788 A AU2136788 A AU 2136788A AU 21367/88 A AU21367/88 A AU 21367/88A AU 2136788 A AU2136788 A AU 2136788A AU 2136788 A AU2136788 A AU 2136788A
Authority
AU
Australia
Prior art keywords
baculovirus
production
expression system
insect cell
cell expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21367/88A
Inventor
Robin Clark
L.L. Houston
Julie A. Lane
Michael Piatak Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of AU2136788A publication Critical patent/AU2136788A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU21367/88A 1987-07-24 1988-07-20 Production of ricin toxins in a baculovirus-insect cell expression system Abandoned AU2136788A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7712687A 1987-07-24 1987-07-24
US077126 1987-07-24
US15377888A 1988-02-08 1988-02-08
US153778 1988-02-08

Publications (1)

Publication Number Publication Date
AU2136788A true AU2136788A (en) 1989-03-01

Family

ID=26758913

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21367/88A Abandoned AU2136788A (en) 1987-07-24 1988-07-20 Production of ricin toxins in a baculovirus-insect cell expression system

Country Status (3)

Country Link
AU (1) AU2136788A (en)
IL (1) IL87193A0 (en)
WO (1) WO1989001037A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626867B2 (en) * 1988-05-31 1992-08-13 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2377097A (en) 1996-04-30 1997-11-19 Cangene Corporation Antiviral ricin-like proteins
KR19980043226A (en) * 1996-12-02 1998-09-05 박영설 Heelless shoe sole with air bag
AU5003597A (en) * 1996-10-28 1998-05-22 Medical University Of South Carolina Methods and compositions for ricin fusion protein immunotoxins to treat cancer and autoimmune disease
US8906676B2 (en) 2004-02-02 2014-12-09 Ambrx, Inc. Modified human four helical bundle polypeptides and their uses
WO2006069220A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Modified human growth hormone
AU2005265163B2 (en) 2004-06-18 2009-10-01 Ambrx, Inc. Novel antigen-binding polypeptides and their uses
WO2006091231A2 (en) 2004-07-21 2006-08-31 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
CN103290084A (en) 2004-12-22 2013-09-11 Ambrx公司 Method for expression and purification of recombinant human growth hormone
SG158149A1 (en) 2004-12-22 2010-01-29 Ambrx Inc Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
NZ555386A (en) 2004-12-22 2011-01-28 Ambrx Inc Formulations of human growth hormone comprising a non-naturally encoded amino acid
CA2590429C (en) 2004-12-22 2014-10-07 Ambrx, Inc. Compositions of aminoacyl-trna synthetase and uses thereof
EP1893229B1 (en) 2005-06-03 2011-10-19 Ambrx, Inc. Improved human interferon molecules and their uses
WO2007021297A1 (en) 2005-08-18 2007-02-22 Ambrx, Inc. COMPOSITIONS OF tRNA AND USES THEREOF
WO2007059312A2 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
CA2662753C (en) 2006-09-08 2016-02-23 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
JP5451390B2 (en) 2006-09-08 2014-03-26 アンブルックス，インコーポレイテッド Transcription of suppressor TRNA in vertebrate cells
EP2069396B1 (en) 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
US8012931B2 (en) 2007-03-30 2011-09-06 Ambrx, Inc. Modified FGF-21 polypeptides and their uses
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
MX338336B (en) 2007-11-20 2016-04-07 Ambrx Inc Modified insulin polypeptides and their uses.
EP2247743B1 (en) 2008-02-08 2016-04-06 Ambrx, Inc. Modified leptin polypeptides and their uses
ES2963062T3 (en) 2008-07-23 2024-03-25 Ambrx Inc Modified bovine G-CSF polypeptides and their uses
TR201802361T4 (en) 2008-09-26 2018-03-21 Ambrx Inc Microorganisms and vaccines dependent on unnatural amino acid replication.
EA019653B1 (en) 2008-09-26 2014-05-30 Амбркс Инк. Modified animal erythropoietin polypeptides and their uses
CA2784793A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
US20120283172A1 (en) 2009-12-21 2012-11-08 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
MX346786B (en) 2010-08-17 2017-03-31 Ambrx Inc Modified relaxin polypeptides and their uses.
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (en) 2010-09-23 2015-04-11 Lilly Co Eli Formulations for bovine granulocyte colony stimulating factor and variants thereof
EP3909596A1 (en) 2014-10-24 2021-11-17 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
MY193457A (en) 2017-02-08 2022-10-14 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78293T1 (en) * 1983-05-27 1992-08-15 Texas A & M Univ Sys METHOD OF GENERATING A RECOMBINANT BACULOVIRUS EXPRESSION VECTOR.
EP0145111B1 (en) * 1983-07-15 1990-05-09 The University Of Warwick Dna sequence coding for a plant toxin of the ricin type, or a portion thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626867B2 (en) * 1988-05-31 1992-08-13 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes

Also Published As

Publication number Publication date
IL87193A0 (en) 1988-12-30
WO1989001037A1 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
AU2136788A (en) Production of ricin toxins in a baculovirus-insect cell expression system
AU6717587A (en) Production of bacterial nitralase in transformed host cell
AU3969689A (en) Bio-reactor cell culture process
AU576551B2 (en) Production plant with modular members
AU588840B2 (en) Improvements in or relating to a process for purifying proteins
AU1478288A (en) Improvements in or relating to a connector
AU7601291A (en) Ether production
AU1482888A (en) Membrane type artificial lung and production thereof
AU4334185A (en) Control of plunger in forming parison
AU2534688A (en) Improvements in or relating to fabric production
AU4292685A (en) Method and cell line for continuous production of retroviruses (htlv-111) related to aids
AU584596B2 (en) Continuous bioreactor and process
AU590651B2 (en) Improved xylene production in a dehydrocyclodimerization process
AU3476789A (en) Benzothiazolones and their production
AU2695484A (en) Battery and process for its production
AU5093085A (en) Improvements in and relating to the production of transfers
AU574194B2 (en) Opticalfibre preform manufacture
AU580592B2 (en) Numbered documents and means for production thereof
AU2575088A (en) Measuring convergence in a mine
AU583489B2 (en) 8alpha-acylamino-ergolines uses and production thereof
AU579188B2 (en) Silica molding and process for its production
AU2021088A (en) Improvements in or relating to hybrid seed production
AU6500486A (en) Product recovery in a dehydrocyclodimerization and other hydrogen producing processes
AU8225187A (en) Reduced-stability alpha-amylase and process for its production
AU2523888A (en) Process for selectively modulating the expression and function of a cell-surface determinant and production of novel human cells produced thereby